Journal of the American Medical Association · 1954 · 203 citations · 5 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyDrug InteractionsPharmaceutical ToxicologyDrug DispositionMedication-related Oral Adverse EffectsHydralazine Therapy
The continued, combined oral administration of hexamethonium chloride and hydralazine hydrochloride (called hyphex therapy) in adequate doses effectively controls severe and malignant forms of hypertension. 1 Hydralazine (Apresoline) hydrochloride is a highly reactive compound that combines with carbonyl and sulfhydryl radicals and has a strong affinity for certain heavy metal ions. 2 Late reactions to this active chemical agent were, therefore, predicted 3 ; these have taken the form of collagen disease in all stages of severity. 4 Others have also described the same phenomena, 5 and one case of pancytopenia has been reported. 6 Of 211 patients receiving both drugs for 9 to 30 months, definite symptoms due to delayed toxic effects of hydralazine developed in 17 (8.1%). The preceding period of combined medication (hyphex) varied from 2 to 22 months, and the total ingestion of the offending drug ranged from 25 to 350 gm. (table 1). At its mildest
5
Studies on the Control of Hypertension by Hyphex
John D. Morrow, Henry A. Schroeder, H. Mitchell Perry · Circulation · 1953 · 194 citations · Full text
Studies on the Control of Hypertension by Hyphex
Henry A. Schroeder, John D. Morrow, H. Mitchell Perry · Circulation · 1953 · 70 citations
A method of quantitating 1-hydrazinophthalazine in body fluids.